Literature DB >> 2647639

Histocompatibility antigens in primary and metastatic squamous cell carcinoma of the larynx.

F Esteban1, A Concha, C Huelin, M Pérez-Ayala, S Pedrinaci, F Ruiz-Cabello, F Garrido.   

Abstract

A series of 38 primary laryngeal and hypopharyngeal tumours, 15 lymph-node metastases and normal tissue were evaluated in frozen sections for the expression of MHC class I and II antigens, using monomorphic monoclonal antibodies (MAbs) to HLA-ABC, beta 2-microglobulin, DR, DP, DQ, HLA-B and polymorphic HLA-ABC antigens. Normal distant mucosa of larynx reacted to anti-class I antibodies but not to anti-class II. In 9 primary tumours (23.7%) HLA class I antigens were not observed. The remaining 29 showed a strong reaction to not observed. The remaining 29 showed a strong reaction to anti-HLA-ABC (heavy chain) and anti-beta 2-microglobulin, although in 3 cases out of 29 no staining was observed with anti-HLA-B locus-specific MAbs. These selective losses were confirmed using the corresponding anti-HLA polymorphic MAbs. For HLA class II molecules, only DR was observed in 3 of 38 cases. Defective HLA class I expression statistically correlates with high scores according to Jakobsson's criteria for histopathological tumour grading. Loss of HLA-ABC antigens was most frequent among the cases with poor differentiation (6/8 cases). On the contrary, class II antigen expression was correlated with a well differentiated pattern and a more favourable prognosis (p less than 0.001). We have found differences in HLA class I expression when comparing primary tumours and autologous metastases (3/9 cases). Immunoprecipitation and SDS-PAGE of class I antigens, Northern and Southern blot analyses of MHC class I genes were performed. We have not detected class I gene rearrangement using HLA coding and locus-specific non-coding probes. However, we have found a class I transcription defect that corresponds with a class-I-negative phenotype.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2647639     DOI: 10.1002/ijc.2910430316

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  22 in total

Review 1.  Human leukocyte antigen (HLA) class I defects in head and neck cancer: molecular mechanisms and clinical significance.

Authors:  Robert L Ferris; Jennifer L Hunt; Soldano Ferrone
Journal:  Immunol Res       Date:  2005       Impact factor: 2.829

Review 2.  Cell adhesion molecules of the immunoglobulin supergene family and their role in malignant transformation and progression to metastatic disease.

Authors:  J P Johnson
Journal:  Cancer Metastasis Rev       Date:  1991-05       Impact factor: 9.264

3.  Mitomycin C directly augments the expression of HLA-DR antigen in a gastric carcinoma cell line.

Authors:  H Inoue; M Adachi; S Arinaga; H Ueo; T Akiyoshi
Journal:  Med Oncol       Date:  1994       Impact factor: 3.064

Review 4.  Biologic markers, cellular differentiation, and metastatic head and neck cancer.

Authors:  S P Schantz
Journal:  Eur Arch Otorhinolaryngol       Date:  1993       Impact factor: 2.503

5.  In vivo infiltration of mononuclear cells in squamous cell carcinoma of the head and neck correlates with the ability to expand tumour-infiltrating T cells in vitro and with the expression of MHC class I antigens on tumour cells.

Authors:  J Hald; N Rasmussen; M H Claesson
Journal:  Cancer Immunol Immunother       Date:  1994-12       Impact factor: 6.968

6.  MHC class II expression in pancreatic tumors: a link to intratumoral inflammation.

Authors:  Matthias M Gaida; Thilo Welsch; Esther Herpel; Darjus F Tschaharganeh; Lars Fischer; Peter Schirmacher; G Maria Hänsch; Frank Bergmann
Journal:  Virchows Arch       Date:  2011-11-27       Impact factor: 4.064

7.  Loss of expression of antigen-presenting molecules in human pancreatic cancer and pancreatic cancer cell lines.

Authors:  H Pandha; A Rigg; J John; N Lemoine
Journal:  Clin Exp Immunol       Date:  2007-04       Impact factor: 4.330

8.  HLA-DR expression is associated with excellent prognosis in squamous cell carcinoma of the larynx.

Authors:  F Esteban; F Ruiz-Cabello; A Concha; M Pérez-Ayala; J A Sánchez-Rozas; F Garrido
Journal:  Clin Exp Metastasis       Date:  1990 Jul-Aug       Impact factor: 5.150

9.  Expression of MHC class I and class II antigens in primary breast carcinomas and synchronous nodal metastases.

Authors:  A Maiorana; A M Cesinaro; R A Fano; G Collina
Journal:  Clin Exp Metastasis       Date:  1995-01       Impact factor: 5.150

10.  High resolution human leukocyte antigen (HLA) class I and class II allele typing in Mexican mestizo women with sporadic breast cancer: case-control study.

Authors:  David Cantú de León; Delia Pérez-Montiel; Verónica Villavicencio; Alejandro García Carranca; Alejandro Mohar Betancourt; Victor Acuña-Alonzo; Alberto López-Tello; Gilberto Vargas-Alarcón; Rodrigo Barquera; Neng Yu; Edmond J Yunis; Julio Granados
Journal:  BMC Cancer       Date:  2009-02-05       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.